|
Market Closed -
Nasdaq
23:00:00 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7888 USD | +7.32% |
|
-4.65% | +13.87% |
| Market Cap | 34.94M 31.18M 28.98M 26.36M 49.6M 3.31B 50.49M 348M 136M 1.73B 131M 128M 5.52B | P/E 2026 * |
-1.25x | P/E 2027 * | -1.46x |
|---|---|---|---|---|---|
| Enterprise Value | 34.94M 31.18M 28.98M 26.36M 49.6M 3.31B 50.49M 348M 136M 1.73B 131M 128M 5.52B | EV / Sales 2026 * |
4.66x | EV / Sales 2027 * | 8.12x |
| Free-Float |
85.18% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ELUT | Delayed | |
CBOE
| ELUT | Real-time |
Last Transcript: Elutia Inc.
| 1 day | +7.32% | ||
| 1 week | -4.65% | ||
| Current month | -0.15% | ||
| 1 month | -1.40% | ||
| 3 months | -17.82% | ||
| 6 months | -32.58% | ||
| Current year | +13.87% |
| 1 week | 0.71 |  | 0.8 |
| 1 month | 0.67 | | 0.9 |
| Current year | 0.6 | | 1.38 |
| 1 year | 0.5 | | 1.38 |
| 3 years | 0.5 | | 5.24 |
| 5 years | 0.5 | | 9.01 |
| 10 years | 0.5 | | 18.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | 52 | - | |
Charles Mills
CEO | Chief Executive Officer | 54 | 21/06/2022 |
Matthew Ferguson
DFI | Director of Finance/CFO | 58 | 28/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Rakin
CHM | Chairman | 65 | 01/11/2015 |
Charles Mills
BRD | Director/Board Member | 54 | 01/11/2015 |
Brigid Makes
BRD | Director/Board Member | 70 | 01/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 A | Exercice | Founder | 63,884 | 0.1445% | ||
| 9/10/26 A | Exercice | Founder | 29,269 | 0.0662% | ||
| 9/10/26 A | Exercice | Chief Financial Officer | 29,486 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.32% | -4.65% | -11.85% | -44.45% | 34.94M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,116B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 610B | |
| -0.03% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 358B | |
| -0.79% | +5.25% | +32.00% | +49.36% | 366B | |
| -1.25% | +4.43% | +19.21% | +42.64% | 288B | |
| -1.51% | +4.23% | -0.38% | +13.98% | 261B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 235B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 195B | |
| Average | +0.96% | +4.27% | +29.98% | +51.50% | 392.98B | |
| Weighted average by Cap. | +0.35% | +4.93% | +38.23% | +71.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.5M 6.69M 6.22M 5.66M 10.65M 710M 10.84M 74.74M 29.24M 371M 28.15M 27.55M 1.19B | 4.3M 3.84M 3.57M 3.24M 6.1M 407M 6.21M 42.85M 16.77M 212M 16.14M 15.79M 680M |
| Net income | -27.3M -24.37M -22.65M -20.6M -38.76M -2.59B -39.46M -272M -106M -1.35B -102M -100M -4.32B | -23.6M -21.07M -19.58M -17.81M -33.51M -2.24B -34.11M -235M -92.02M -1.17B -88.56M -86.69M -3.73B |
| Net Debt | - | - |
Employees
26
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | $0.7888 | +7.32% | 123,877 |
| 14/10/26 | $0.7350 | -4.94% | 293,262 |
| 13/10/26 | $0.7732 | -1.75% | 36,584 |
| 12/10/26 | $0.7870 | -4.39% | 69,836 |
| 09/10/26 | $0.8231 | -0.51% | 19,975 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7888USD
Average target price
5.000USD
Spread / Average Target
+533.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ELUT Stock
Select your edition
All financial news and data tailored to specific country editions
